The block of the interaction of CXCL12 and its receptors CXCR4/CXCR7, or the deactivation of the downstream Rho/Rock and PI3K/AKT signalling pathway, might be a new approach to approach to the treatment of PAS. Here, CXCL12 is linked to gonorrhea.